Prodotti della ricerca

 

Professore di Economia Politica
Prorettore Delegato per la ricerca scientifica, i rapporti istituzionali e l’innovazione

Blog personale: http://francescopigliaru.blogspot.com

UNICA IRIS Institutional Research Information System

IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi di Cagliari dal mese di luglio 2015.

Mostra risultati da 1 a 16 di 16
TitoloData di pubblicazioneAutoriTipoAbstract
Metabolomic Analysis of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors2020CAOCCI, GIOVANNI  ; DEIDDA, MARTINO  ; NOTO, ANTONIO  ; GRECO, MARIANNA  ; MULAS, OLGA  ; FATTUONI, CLAUDIA  ; MERCURO, GIUSEPPE  ; LA NASA, GIORGIO  ; CADEDDU DESSALVI, CHRISTIAN  1 Contributo su Rivista::1.1 Articolo in rivista
Increased incidence of infection in patients with myelofibrosis and transfusion-associated iron overload in the clinical setting2020CAOCCI, GIOVANNI  ; MULAS, OLGA  ; MAINAS, GIORGIA  ; LA NASA, GIORGIO  1 Contributo su Rivista::1.1 Articolo in rivista
Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors2020MULAS, OLGA  ; CAOCCI, GIOVANNI  ; EFFICACE, FABIO  ; LA NASA, GIORGIO  1 Contributo su Rivista::1.1 Articolo in rivista
Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study2020CAOCCI, GIOVANNI  ; MULAS, OLGA  ; EFFICACE, FABIO  ; LA NASA, GIORGIO  1 Contributo su Rivista::1.1 Articolo in rivista-
Favourable outcome of chronic myeloid leukemia co-expressing e13a2 and e14a2 transcripts, treated with nilotinib2020MULAS, OLGA  ; CAOCCI, GIOVANNI  ; LA NASA, GIORGIO  1 Contributo su Rivista::1.1 Articolo in rivista-
Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart2019CAOCCI, GIOVANNI  ; MULAS, OLGA  ; LA NASA, GIORGIO  ; 1 Contributo su Rivista::1.1 Articolo in rivista
Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice2019CAOCCI, GIOVANNI  ; MULAS, OLGA  ; LA NASA, GIORGIO  ; 1 Contributo su Rivista::1.1 Articolo in rivista
Metabolomics Profile of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors2019CAOCCI, GIOVANNI  ; DEIDDA, MARTINO  ; NOTO, ANTONIO  ; CADEDDU DESSALVI, CHRISTIAN  ; GRECO, MARIANNA  ; MULAS, OLGA  ; COCCO, DANIELE  ; FATTUONI, CLAUDIA  ; MERCURO, GIUSEPPE  ; LA NASA, GIORGIO  1 Contributo su Rivista::1.5 Abstract in rivista-
Recurrent arterial occlusive events in patients with chronic myeloid leukemia treated with second- and third-generation tyrosine kinase inhibitors and role of secondary prevention2019CAOCCI, GIOVANNI  ; MULAS, OLGA  ; LA NASA, GIORGIO  ; 1 Contributo su Rivista::1.1 Articolo in rivista
Long-term mortality rate for cardiovascular disease in 656 chronic myeloid leukaemia patients treated with second- and third-generation tyrosine kinase inhibitors2019CAOCCI, GIOVANNI  ; MULAS, OLGA  ; LA NASA, GIORGIO  ; 1 Contributo su Rivista::1.1 Articolo in rivista
Residual peripheral blood CD26+leukemic stem cells in chronic myeloid leukemia patients during TKI therapy and during treatment-free remission2018MULAS, OLGA  ; CAOCCI, GIOVANNI  ; 1 Contributo su Rivista::1.1 Articolo in rivista
Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis2018CAOCCI, GIOVANNI  ; MULAS, OLGA  ; OTERI, ANNUNZIATA MARIA  ; EFFICACE, FABIO  ; CATTANEO, DAVIDE  ; SPECCHIA, GIORGINA  ; LA NASA, GIORGIO  ; 1 Contributo su Rivista::1.1 Articolo in rivista-
HLA-G molecules and clinical outcome in Chronic Myeloid Leukemia2017CAOCCI, GIOVANNI  ; ORRU, SANDRO  ; MULAS, OLGA  ; CARCASSI, CARLO  ; LA NASA, GIORGIO  1 Contributo su Rivista::1.1 Articolo in rivista
Killer immunoglobulin-like receptors can predict TKI treatment-free remission in chronic myeloid leukemia patients2015CAOCCI, GIOVANNI  ; GRECO, MARIANNA  ; RAGATZU, PAOLA  ; MULAS, OLGA  ; CARCASSI, CARLO  ; LA NASA, GIORGIO  1 Contributo su Rivista::1.1 Articolo in rivista
Homozygosity for killer immunoglobin-like receptor haplotype A predicts complete molecular response to treatment with tyrosine kinase inhibitors in chronic myeloid leukemia patients2013LA NASA, GIORGIO  ; CAOCCI, GIOVANNI  ; MULAS, OLGA  ; ORRU, SANDRO  ; FLORIS, ANDREA  ; CARCASSI, CARLO  1 Contributo su Rivista::1.1 Articolo in rivista
Kir haplotype aa is a possible predictive marker of complete molecular response to tyrosine kinase inhibitors in patients with chronic myeloid leukemia2013CAOCCI, GIOVANNI  ; LA NASA, GIORGIO  ; MULAS, OLGA  ; ORRU, SANDRO  ; CARCASSI, CARLO  1 Contributo su Rivista::1.5 Abstract in rivista-
   
credits unica.it | accessibilità Università degli Studi di Cagliari
C.F.: 80019600925 - P.I.: 00443370929
note legali | privacy

Nascondi la toolbar